Dr. Reddy's Laboratories Faces Shift in Market Evaluation Amid Mixed Performance Metrics
Dr. Reddy's Laboratories has undergone a recent evaluation adjustment by MarketsMojo, reflecting a change in its technical outlook. The company shows mixed performance metrics, with a slight decline in stock returns over the past year, while profits and net sales have seen growth. Its low debt-to-equity ratio highlights strong fundamentals.
Dr. Reddy's Laboratories, a prominent player in the Pharmaceuticals & Biotechnology sector, has recently experienced an adjustment in evaluation by MarketsMOJO. This revision reflects a shift in the technical outlook, indicating a transition from a bullish to a mildly bullish trend. The company's performance metrics reveal a mixed picture. Over the past year, Dr. Reddy's stock has returned -4.82%, while profits have seen a modest increase of 2.1%. The stock's current price stands at 1274.25, with a 52-week high of 1,404.60 and a low of 1,025.90. Notably, the company maintains a low debt-to-equity ratio, averaging at 0 times, which underscores its strong long-term fundamental strength.
Additionally, Dr. Reddy's has demonstrated healthy growth in net sales, with an annual growth rate of 13.13%, and an operating profit growth of 31.97%. The return on equity (ROE) averages at 15.68%, indicating robust profitability per unit of shareholders' funds.
With high institutional holdings at 63.1%, Dr. Reddy's Laboratories continues to be a significant entity in the market landscape.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
